Evidence map›Paper›PMID 40884686›Full record

ArticleMedical oncology (Northwood, London, England)2025

Effect of pyrogallol nanocomposite on miRNA and its associated pathways during radiation-induced toxicity in small intestine of irradiated Balb/C mice.

Sreemadhi Parvathikandhan, Sivaa Varshini Anbarasu, Krithika Narayanan, Rubin Nishanth Armstrong, Vadivel Vellingiri, Devipriya Nagarajan, Rekha Arcot, Musab Hamed Saeed, Muthu Thiruvengadam, Naiyf S Alharbi

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sreemadhi ParvathikandhanSchool of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, Tamil Nadu, 613401, India.
Sivaa Varshini AnbarasuSchool of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, Tamil Nadu, 613401, India.
Krithika NarayananSchool of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, Tamil Nadu, 613401, India.
Rubin Nishanth ArmstrongSchool of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, Tamil Nadu, 613401, India.
Vadivel VellingiriSchool of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, Tamil Nadu, 613401, India.
Devipriya NagarajanSchool of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, Tamil Nadu, 613401, India. devipriya@scbt.sastra.edu.
Rekha ArcotDr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune, Maharashtra, 411018, India.
Musab Hamed SaeedDepartment of Clinical Sciences, College of Dentistry, Ajman University, Ajman, United Arab Emirates.
Muthu ThiruvengadamDepartment of Applied Bioscience, College of Sanghuh Life Science, Konkuk University, Seoul, 05029, Republic of Korea. muthu@konkuk.ac.kr.
Naiyf S AlharbiDepartment of Botany and Microbiology, College of Science, King Saud University, Riyadh, 11451, 2455, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is the abnormal and uncontrolled growth of cells that changes the structure of nearby cells or tissues. Cancer treatment strategies include surgery, chemotherapy, immunotherapy, and radiotherapy. Radiation therapy is one of the most frequently used cancer treatment modalities. Ionizing radiation not only kills cancer cells but also affects surrounding normal cells, causing extensive damage to all organs including the liver, kidneys, and intestines. Thus, identifying radioprotective agents is crucial to reduce the side effects of radiotherapy. Recently, nanocomposites have played a crucial role in cancer diagnosis and treatment as well as in reducing radiation-induced side effects. In this study, we tested pyrogallol nanocomposites for radiation-induced toxicity. Pyrogallol is a catechin molecule found in oak, eucalyptus, and other hardwood plants and is an amino polysaccharide produced by the deacetylation of chitin found in crustaceans and insects. In this study, pyrogallol and chitosan nanoparticles were blended to form a pyrogallol nanocomposite (PyNC). We investigated changes in miRNA expression in the small intestine of irradiated BALB/c mice. BALB/c mice were divided into four groups: control, irradiated (10 Gy), irradiated (10 Gy) + PyNC (40 μg/kg body weight), and PyNC alone (40 μg/kg body weight). We analyzed miRNA expression, apoptotic genes, inflammatory genes, and fibrotic genes using real-time PCR, and apoptotic proteins were analyzed by Western blotting and immunohistochemistry. Our results revealed that radiation modulated miRNA expression patterns regulated by PyNC. Analysis of the miRNA online database revealed that the miRNA targets were casp9, IL7, IL7R, JUN, MMP9, Bcl2, and SMAD4. Furthermore, real-time PCR, Western blotting, and immunohistochemistry analyses revealed that radiation increased apoptotic proteins, inflammatory markers, and TGF-β and its associated molecules, which effectively decreased upon PyNC treatment in irradiated BALB/c mice. Additionally, PyNC treatment inhibited DNA fragmentation and oxidative stress in the small intestine of irradiated BALB/c mice. Overall, we suggest that PyNC effectively protects the small intestine from radiation-induced toxicity by altering miRNAs and their associated molecular targets, including apoptosis, inflammation, and fibrosis. However, overexpression or knockout studies of miRNAs during radiation-induced toxicity are warranted.

Indexed as

Intestine, SmallMicroRNAsNanocompositesPyrogallolRadiation Injuries, ExperimentalRadiation-Protective AgentsAnimalsMaleMiceMice, Inbred BALB CMicroRNAsPyrogallolRadiation-Protective AgentsInflammationmicroRNAPyrogallol nanocompositeRadiationTGF-β

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.